Sign in
American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease
Journal article   Peer reviewed

American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease

Gary R Lichtenstein, Maria T Abreu, Russell Cohen, William Tremaine and American Gastroenterological Association
Gastroenterology (New York, N.Y. 1943), Vol.130(3), pp.940-987
2006-03
PMID: 16530532

Abstract

Inflammatory Bowel Diseases - drug therapy Recurrence Azathioprine - administration & dosage Humans Antibodies, Monoclonal - adverse effects Mercaptopurine - administration & dosage Antibodies, Monoclonal - therapeutic use Methotrexate - therapeutic use Adrenal Cortex Hormones - therapeutic use Adrenal Cortex Hormones - adverse effects Calcineurin Inhibitors Cyclosporine - therapeutic use Methotrexate - adverse effects Drug Interactions Mycophenolic Acid - analogs & derivatives Mycophenolic Acid - therapeutic use Infliximab Immunologic Factors - therapeutic use

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.120 Inflammatory Bowel Diseases & Infections
1.120.139 Ulcerative Colitis
Web Of Science research areas
Gastroenterology & Hepatology
ESI research areas
Clinical Medicine

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details